PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC12830260::ACT034439

TXM-CB3

Evidence text

Paper-level observation

Fig. 6C: CB3 treatment influenced anxiety-like behavior, as evidenced by the increased time spent in the center zone compared to control animals (p > 0.05).
textConfidence: medium

Assay observation

Activity
Other
Subtype
Not reported by source
Measure
other
Comparator
>
Raw observation
increased time spent in the center zone
Normalized measurement
>0.05%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
ACCPCNH
Standardization
ready simple

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

DOI 10.1016/j.redox.2026.104021 PMC12830260
Parent mention

Related peptide identities

PEPDIA-PLP-000024

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.